Haw Par Corporation Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other
pharmaceutical manufacturers in Asia:
Huons Global Co Ltd
of South Korea
sales of 163.71 billion Korean Won [US$146.52 million]
of which 112%
was Pharmaceutical Department),
(9.26 billion Indian Rupees [US$141.44 million]
of which 61%
was Pharmaceutical Products), and
Autobio Diagnostics Co Ltd
based in China
(980.22 million Chinese Renmimbi [US$142.39 million]
of which 95%
was In vitro diagnosis).
Haw Par Corporation Limited reported sales of 201.64 million Singapore Dollars (US$144.14 million)
December of 2016.
increase of 12.8%
versus 2015, when the company's sales were 178.83 million Singapore Dollars.
Sales at Haw Par Corporation Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 52%).